What to Expect from Cardiovascular Life at 85?
作者信息
Kok Wouter
机构信息
Amsterdam University Medical Center , Amsterdã - Holanda.
出版信息
Arq Bras Cardiol. 2021 Jun;116(6):1037-1038. doi: 10.36660/abc.20210138.
Abstract
摘要
相似文献
1
What to Expect from Cardiovascular Life at 85?
Arq Bras Cardiol. 2021 Jun;116(6):1037-1038. doi: 10.36660/abc.20210138.
2
The cardiovascular situation today in life insurance underwriting.
J Insur Med (1946). 1947 Mar-May;2(2):55-9.
3
Life insurance for the young cardiovascular patient.
JAMA. 1963 May 18;184:593-4. doi: 10.1001/jama.1963.73700200014025c.
4
The heart and arteries in mid-life.
J Am Geriatr Soc. 1954 Mar;2(3):139-45. doi: 10.1111/j.1532-5415.1954.tb02691.x.
5
OBESITY, longevity, and cardiovascular disease.
Heart Bull. 1955 Sep-Oct;4(5):82-6.
6
Pediatric hypertension: Cardiovascular prevention must begin early in life.
Rev Port Cardiol (Engl Ed). 2019 Mar;38(3):203-204. doi: 10.1016/j.repc.2019.04.001. Epub 2019 Apr 24.
7
[Physiology and pathology of the cardiovascular system].
Vestn Akad Med Nauk SSSR. 1955(2):71-8.
8
Diseases of the cardiovascular system.
Annu Rev Med. 1951;2:51-92. doi: 10.1146/annurev.me.02.020151.000411.
9
Diseases of the cardiovascular system.
Voen Med Zh. 1945 Jun:42.
10
Diseases of the cardiovascular system; surgical.
Annu Rev Med. 1956;7:291-308. doi: 10.1146/annurev.me.07.020156.001451.
本文引用的文献
1
Prognostic Value of Plasma NT-proBNP levels in Hospitalized Patients Older than 80 Years of Age in a Hospital in Beijing, China.
Arq Bras Cardiol. 2021 Jun;116(6):1027-1036. doi: 10.36660/abc.20190158.
2
N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people.
Geroscience. 2021 Apr;43(2):845-857. doi: 10.1007/s11357-020-00249-2. Epub 2020 Aug 11.
3
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019.
Arq Bras Cardiol. 2019 Nov 4;113(4):787-891. doi: 10.5935/abc.20190204.
4
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Heart. 2019 Aug;105(15):1182-1189. doi: 10.1136/heartjnl-2018-314173. Epub 2019 Apr 8.
5
Cardiovascular Disease Epidemiology in Portuguese-Speaking Countries: data from the Global Burden of Disease, 1990 to 2016.
Arq Bras Cardiol. 2018 Jun;110(6):500-511. doi: 10.5935/abc.20180098.
6
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure.
Int J Cardiol. 2018 Nov 15;271:324-330. doi: 10.1016/j.ijcard.2018.04.006.
7
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
8
Geriatric Cardiology: An Emerging Discipline.
Can J Cardiol. 2016 Sep;32(9):1056-64. doi: 10.1016/j.cjca.2016.03.019. Epub 2016 Apr 7.
9
Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study.
J Am Coll Cardiol. 2015 Mar 17;65(10):976-83. doi: 10.1016/j.jacc.2014.12.040.
10
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
Age (Dordr). 2014 Jun;36(3):9660. doi: 10.1007/s11357-014-9660-1. Epub 2014 May 8.
Zotero 插件